|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiovascular Function and Treatment in β-Thalassemia Major: A Consensus Statement From the American Heart Association显示文摘 | Dudley J. Pennell James E. Udelson Andrew E. Arai Biykem Bozkurt Alan R. Cohen Renzo Galanello Timothy M. Hoffman Michael S. Kiernan Stamatios Lerakis Antonio Piga John B. Porter John Malcolm Walker John Wood | 2013 | Circulation2013，，3： | 3 |
| 2 | Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance显示文摘 | A. Selcuk Adabag Barry J. Maron Evan Appelbaum Caitlin J. Harrigan Jacqueline L. Buros C. Michael Gibson John R. Lesser Constance A. Hanna James E. Udelson Warren J. Manning Martin S. Maron | 2008 | Journal of the American College of Cardiology2008，，14： | 2 |
| 3 | Steps forward in the assessment of myocardial viability in left ventricular function显示文摘 | Udelson JD | 1998 | Circulation1998，97，： | 1 |
| 4 | Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction-, an international, multicenter, randomized, placebo-controlled trial显示文摘 | Udelson JE Orlandi C Ouyang J | 2008 | J AmColl Cardiol2008，52，19： | 1 |
| 5 | A multicenter, randomized, double -blind, placebo -controlled studay of tolvaptan monotherapy compared to fumsemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction(VICTOR study)显示文摘 | Udelson JE Bilsker M Hauptman PJ | 2011 | J Cardiac Fail2011，17，12： | 1 |
| 6 | Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (AC TIV in CHF) trial显示文摘 | Rossi J Bayram M Udelson JE | 2007 | Acute Card Care2007，9，2： | 1 |
| 7 | Vasopressin V2 receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia显示文摘 | GHEORGHIADE M GOTI'LIEB SS UDELSON JE | 2006 | Am J Cardiol2006，97，7： | 1 |
| 8 | The Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy显示文摘 | Martin S. Maron Iacopo Olivotto Barry J. Maron Sanjay K. Prasad Franco Cecchi James E. Udelson Paolo G. Camici | 2009 | Journal of the American College of Cardiology2009，，9： | 1 |
| 9 | Multicenter, ran- domized, double-blind, placebo-controlled studay on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dys- funetion显示文摘 | Udelson JE McGrew FA Flores E | 2007 | J Am Coil Cardiol2007，49，22： | 1 |
| 10 | Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular systolic dysfunction:a meta-analysis显示文摘 | Shaw LJ Hachamovitch R Udelson JE | 2002 | J Am Coll Cardiol2002，39，7： | 1 |
| 11 | Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, plaeeboeontrolled trial 显示文摘 | Udelson JE Orlandi C Ouyang J | 2008 | J Am Coll Cardiol2008，52，19： | 1 |
| 12 | Left ventrlcular diastolic dysfunction as a cause of congestive heart failure: Mechanisms and management显示文摘 | Bonow RO Udelson JE | 1992 | Ann Intern Med1992，117，6： | 1 |
| 13 | Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy显示文摘 | Martin S. Maron John J. Finley J Martijn Bos Thomas H. Hauser Warren J. Manning Tammy S. Haas John R. Lesser James E. Udelson Michael J. Ackerman Barry J. Maron | 2008 | Circulation2008，，15： | 1 |
| 14 | Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure: The Precise Trial显示文摘 | Milton Packer Wilson S. Colucci Jonathan D. Sackner-Bernstein Chang-seng Liang David A. Goldscher Israel Freeman Marrick L. Kukin Vithal Kinhal James E. Udelson Marc Klapholz Stephen S. Gottlieb David Pearle Robert J. Cody John J. Gregory Nikki E. Kantrow | 1996 | Circulation1996，，： | 1 |
| 15 | Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction 显示文摘 | UDELSON J ORLAND C OUYANG J | 2008 | J Am Coll Cardiol2008，52，19： | 1 |
| 16 | Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure显示文摘 | James E. Udelson William B. Smith Grady H. Hendrix Christopher A. Painchaud Maha Ghazzi Ignatius Thomas Jalal K. Ghali Paulina Selaru Francoise Chanoine Milton L. Pressler Marvin A. Konstam | 2001 | Circulation: Journal of the American Heart Association2001，，20： | 1 |
| 17 | Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome显示文摘 | Barry J. Maron Michael J. Ackerman Rick A. Nishimura Reed E. Pyeritz Jeffrey A. Towbin James E. Udelson | 2005 | Journal of the American College of Cardiology2005，，8： | 1 |
| 18 | Acute hemodynamic effects of conlvaptan,a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure 显示文摘 | UDELSON JE SMITH WB HENDRIX GH | 2001 | Circulation2001，104，20： | 1 |
| 19 | A multicenter,randomized,double-blind,placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction显示文摘 | Udelson JE Bilsker M Hauptman PJ | 2011 | Journal of Cardiac Failure2011，17，12： | 1 |
| 20 | Effectiveness of preload reserve as determinant of clinical status in patients with left ventricular systolic dysfunction显示文摘 | Konstam MA Kronenbery MW Udelson JE | 1990 | Am J Cardiol1990，69，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员